Anybody know what happened with AstroRX?

[csommers]

AstroRx treatment for ALS – ALS News Today

An injection of AstroRx, a cell therapy by Kadimastem, showed promise in slowing ALS in a Phase 1/2 trial. A U.S. Phase 2a trial is planned.

alsnewstoday.com

Pipeline | Kadimastem

ALS Clinical trial ALS ניוון שרירים ניסוי קליני ישראל קדימהסטם קדימה סטם

www.kadimastem.com

 

[lgelb]

The IIa trial, which will inject the therapy every 3 months, has been delayed due to a merger with NLS Pharmaceutics, set to close this quarter. The trial is planned to begin post-merger. The new NASDAQ ticker will be NCEL (NucelX).